1. |
Perdomo CM, Cohen RV, Sumithran P, et al. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet, 2023, 401(10382): 1116-1130.
|
2. |
Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al. Obesity management in adults: a review. JAMA, 2023, 330(20): 2000-2015.
|
3. |
Boškoski I, Pontecorvi V, Ibrahim M, et al. Curriculum for bariatric endoscopy and endoscopic treatment of the complications of bariatric surgery: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy, 2023, 55(3): 276-293.
|
4. |
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet, 1982, 1(8265): 198-199.
|
5. |
Weight-loss and weight-management devices. FDA. https://www.fda.gov/medical-devices/products-and-medical-procedures/weight-loss-and-weight-management-devices.
|
6. |
Bazerbachi F, Haffar S, Sawas T, et al. Fluid-filled versus gas-filled intragastric balloons as obesity interventions: a network meta-analysis of randomized trials. Obes Surg, 2018, 28(9): 2617-2625.
|
7. |
Swei E, Almuhaidb A, Sullivan S, et al. Comparison of the efficacy and safety of the FDA-approved intragastric balloon systems in a clinical setting. J Clin Gastroenterol, 2023, 57(6): 578-585.
|
8. |
Abu Dayyeh BK, Maselli DB, Rapaka B, et al. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet, 2021, 398(10315): 1965-1973.
|
9. |
Loo JH, Lim YH, Seah HL, et al. Intragastric balloon as bridging therapy prior to bariatric surgery for patients with severe obesity (BMI ≥ 50 kg/m2): a systematic review and meta-analysis. Obes Surg, 2022, 32(2): 489-502.
|
10. |
Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc, 2013, 78(3): 530-535.
|
11. |
Fogel R, De Fogel J, Bonilla Y, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc, 2008, 68(1): 51-58.
|
12. |
Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet, 2022, 400(10350): 441-451.
|
13. |
Alqahtani AR, Elahmedi M, Aldarwish A, et al. Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score-matched comparative study. Gastrointest Endosc, 2022, 96(1): 44-50.
|
14. |
Beran A, Matar R, Jaruvongvanich V, et al. Comparative effectiveness and safety between endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a meta-analysis of 6 775 individuals with obesity. Obes Surg, 2022, 32(11): 3504-3512.
|
15. |
Gudur AR, Geng CX, Kshatri S, et al. Comparison of endoscopic sleeve gastroplasty versus surgical sleeve gastrectomy: a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database analysis. Gastrointest Endosc, 2023, 97(1): 11-21.
|
16. |
Gudur AR, Geng CX, Podboy A. Early safety and efficacy comparison of endoscopic bariatric interventions. Surg Obes Relat Dis, 2023, 19(10): 1148-1153.
|
17. |
Rattner D, Kalloo A; ASGE/SAGES Working Group. ASGE/SAGES Working Group on natural orifice translumenal endoscopic surgery. October 2005. Surg Endosc, 2006, 20(2): 329-333.
|
18. |
Swanstrom LL, Kozarek R, Pasricha PJ, et al. Development of a new access device for transgastric surgery. J Gastrointest Surg, 2005, 9(8): 1129-1136.
|
19. |
Mellinger JD, MacFadyen BV, Kozarek RA, et al. Initial experience with a novel endoscopic device allowing intragastric manipulation and plication. Surg Endosc, 2007, 21(6): 1002-1005.
|
20. |
Espinós JC, Turró R, Mata A, et al. Early experience with the Incisionless Operating Platform™ (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg, 2013, 23(9): 1375-1383.
|
21. |
Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring), 2017, 25(2): 294-301.
|
22. |
Lopez-Nava G, Asokkumar R, Turró Arau R, et al. Modified primary obesity surgery endoluminal (POSE-2) procedure for the treatment of obesity. VideoGIE, 2020, 5(3): 91-93.
|
23. |
Lopez Nava G, Arau RT, Asokkumar R, et al. Prospective multicenter study of the primary obesity surgery endoluminal (POSE 2.0) procedure for treatment of obesity. Clin Gastroenterol Hepatol, 2023, 21(1): 81-89.
|
24. |
Al Khatry M, Abu Dayyeh BK. The primary obesity surgery endoluminal 2.0 enfolding technique (POSE 2.0et): modification to enhance efficiency and increase restriction. Obes Surg, 2023, 33(6): 1953-1954.
|
25. |
Huberty V, Ibrahim M, Hiernaux M, et al. Safety and feasibility of an endoluminal-suturing device for endoscopic gastric reduction (with video). Gastrointest Endosc, 2017, 85(4): 833-837.
|
26. |
Huberty V, Machytka E, Boškoski I, et al. Endoscopic gastric reduction with an endoluminal suturing device: a multicenter prospective trial with 1-year follow-up. Endoscopy, 2018, 50(12): 1156-1162.
|
27. |
Huberty V, Boskoski I, Bove V, et al. Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial. Gut, 2020 Oct 28: gutjnl-2020l-322026l. doi: 10.1136/gutjnl-2020-322026.
|
28. |
Pizzicannella M, Lapergola A, Fiorillo C, et al. Does endoscopic sleeve gastroplasty stand the test of time? Objective assessment of endoscopic ESG appearance and its relation to weight loss in a large group of consecutive patients. Surg Endosc, 2020, 34(8): 3696-3705.
|
29. |
Nyström M, Machytka E, Norén E, et al. Aspiration therapy as a tool to treat obesity: 1- to 4-year results in a 201-patient multi-center post-market European registry study. Obes Surg, 2018, 28(7): 1860-1868.
|
30. |
Abeid M, Kaddah T. Endoscopic band ligation for weight loss. Endoscopy, 2021, 53(8): E287-E288. doi: doi: 10.1055/a-1264-6360.
|
31. |
Yen YA, Wang CC, Sung WW, et al. Intragastric injection of botulinum toxin A for weight loss: A systematic review and meta-analysis of randomized controlled trials. J Gastroenterol Hepatol, 2022, 37(6): 983-992.
|
32. |
Neto MG, Silva LB, Grecco E, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40 000 cases. Surg Obes Relat Dis, 2018, 14(2): 151-159.
|
33. |
Espinet Coll E, Del Pozo García AJ, Turró Arau R, et al. Spanish Intragastric Balloon Consensus Statement (SIBC): practical guidelines based on experience of over 20 000 cases. Rev Esp Enferm Dig, 2023, 115(1): 22-34.
|
34. |
ASGE/ASMBS Task Force on endoscopic bariatric therapy. A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis, 2011, 7(6): 672-682.
|
35. |
Estimate of Bariatric Surgery. Numbers, 2011-2022. https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers/.
|
36. |
Salminen P, Kow L, Aminian A, et al. IFSO consensus on definitions and clinical practice guidelines for obesity management—an International Delphi Study. Obes Surg, 2024, 34(1): 30-42.
|